Dr. Andrzej Pawel Wojcieszynski, MD

Dr. Wojcieszynski practices at Cpmg in Denver, Colorado.

Dr. Wojcieszynski's NPI, 1316203003, was assigned on April 6, 2012. Dr. Wojcieszynski graduated from Jefferson Medical College of Thomas Jefferson University in 2012. Dr. Wojcieszynski holds Colorado license DR.0066114.

Dr. Wojcieszynski's primary practice is Cpmg, at 10350 E Dakota Ave, Denver, CO 80247 in Arapahoe County. The practice phone is (303) 338-4545.

Dr. Wojcieszynski's primary practice is Cpmg in Denver, Colorado. Dr. Wojcieszynski is also affiliated with Saint Joseph Hospital. The medical group on file is Colorado Permanente Medical Group. Dmand AI also links Dr. Wojcieszynski to 2 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wojcieszynski practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Wojcieszynski's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dmand AI has Dr. Wojcieszynski's licenses on file in 2 states: Colorado and Pennsylvania.

CMS data shows 11 Medicare services from Dr. Wojcieszynski across 1 procedure code in 2024, for 23 Medicare patients. Medicare paid $1,360 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 23 Medicare patients who saw Dr. Wojcieszynski in 2024. 74% of them have cancer, and 57% have high cholesterol. Their average risk score is 1.41, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Wojcieszynski's median patient age at 65, with 58% women.

In 2024, Dr. Wojcieszynski wrote 115 Medicare Part D claims for 54 patients. 98% of them were for generic drugs. CMS names the drug for 20 of them, across 1 drug with 11 or more claims each, at $301 in total drug cost. In 2020, CMS named 14 claims across 1 drug.

Dr. Wojcieszynski accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 33 papers to Dr. Wojcieszynski, published from 2012 to 2025. 2021 was the busiest year, with 4. The most frequent topics are Chemoradiotherapy, Adenocarcinoma and Radiotherapy Dosage. Dr. Wojcieszynski has published most often in Int J Radiat Oncol Biol Phys. Dr. Wojcieszynski's most frequent co-authors are James M. Metz, MD, John Peter Plastaras, MD and Michael F. Bassetti.

CMS Open Payments shows 7 general payments to Dr. Wojcieszynski from 6 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Elekta, Inc. paid the most, $151.

Dr. Wojcieszynski graduated from Jefferson Medical College of Thomas Jefferson University in 2012.